Pfizer, Mylan Beat EpiPen Antitrust Suit, For Now
A Kansas federal judge on Monday tossed a lawsuit alleging Mylan Pharmaceuticals and Pfizer Inc. inflated the price of emergency allergy medication EpiPen, saying the pharmacy operator behind the suit doesn't...To view the full article, register now.
Already a subscriber? Click here to view full article